Brittany Erana, CEO at Jumo Health
What You Should Know:
– Jumo Health, a global leader in optimizing the patient experience in clinical trials announced the appointment of Brittany Erana as its new Chief Executive Officer.
–…
Continue Reading
Clinical practice is currently guided by studies that average over patient outcomes. This may not be the best approach, as different patients may have different treatment responses. Here we extend a method for simulating…
Continue Reading
What You Should Know:
– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new investors Lingotto…
Continue Reading
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue…
Continue Reading
What You Should Know:
– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story…
Continue Reading
The prototype of a machine that can detect tumours in women with dense breast tissue has been developed in Newcastle.
It is part of a research programme being delivered by technology group, Kromek, in partnership…
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading
Israeli startup PhaseV, an AI-enabled clinical development company for life sciences, has secured $50 million in Series A funding in a round co-led by Accel and Insight Partners. Existing investors Viola Ventures, LionBird and EXOR…
Continue Reading
What You Should Know:
– PhaseV, a company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to clinical development raies $50M in Series A funding round co-led by Accel and Insight…
Continue Reading
What You Should Know:
– Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
– The study…
Continue Reading
